Supplier
Washington Institute for Coagulation
Washington Institute for Coagulation was paid $117.02M by Medicaid between Dec 2020 and Dec 2024, across 3 billing codes. Its largest line is J7170, Injection, emicizumab-kxwh, 0.5 mg — 75% of everything it billed.
33Billing provider infoWASHINGTON INSTITUTE FOR COAGULATION
SEATTLE, WA 98101
SEATTLE, WA 98101
33aNPI1023678240assigned 06/19/2019
33bProvider typeSpecialty Pharmacy
28Total paid$117.02M
24GClaims9,179
24DCodes billed3
24AFirst – last monthDec 2020 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 134 | $1.74M | |
| 2021 | 2,063 | $26.64M | |
| 2022 | 2,405 | $30.47M | |
| 2023 | 2,409 | $30.75M | |
| 2024incomplete | 2,168 | $27.43M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J7170 | Injection, emicizumab-kxwh, 0.5 mg | 75% | 3,063 | 2,595 | $88.14M |
| S9430 | Pharmacy compounding and dispensing services | 17% | 5,170 | 3,615 | $20.20M |
| J7192 | Factor viii (antihemophilic factor, recombinant) per i.u., not otherwise specified | 7.4% | 946 | 573 | $8.67M |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKRUSE-JARRES, REBECCA (EXECUTIVE OFFICER)
Parent organizationWA INSTITUTE FOR COAGULATION